| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.71B | — | +35.1% |
| Cost of Revenue | $1.03B | — | +41.6% |
| Gross Profit | $1.68B | — | +31.4% |
| R&D Expense | $343.7M | — | +29.0% |
| SG&A Expense | $33.7M | — | -1.7% |
| Operating Income | $1.16B | — | +34.8% |
| Pre-tax Income | $1.27B | — | +33.1% |
| Income Tax | $248.5M | — | +76.0% |
| Net Income | $1.02B | — | +25.7% |
| EPS (Basic) | $0.81 | — | +24.6% |
| EPS (Diluted) | $0.80 | — | +25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.79B | +42.0% | +51.2% |
| Accounts Receivable | $1.92B | +2.0% | +34.0% |
| Inventory | $2.38B | +5.9% | +21.6% |
| Current Assets | $18.56B | +13.2% | +51.2% |
| Total Assets | $21.66B | +11.4% | +49.2% |
| Current Liabilities | $6.56B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.69B | — | +163.9% |
| Capital Expenditures | $54.5M | — | +91.9% |
| Investing Cash Flow | -$865.3M | — | -13.0% |
| Financing Cash Flow | $0 | — | +100.0% |
| Free Cash Flow | $1.64B | — | +167.2% |
| +110.2% |
| Total Liabilities | $8.17B | +15.4% | +85.9% |
| Stockholders' Equity | $13.49B | +9.0% | +33.3% |